Fresenius Medical Care Ag & CO Kgaa (FME.D.DX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [DXE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 394,363 | 477,001 | 366,256 | 387,000 | 512,443 |
| Income taxes - deferred | -30,487 | 46,493 | N/A | N/A | -44,365 |
| Accounts receivable | -293,141 | 25,678 | 592,845 | -23,000 | -552,721 |
| Accounts payable and accrued liabilities | -105,184 | 63,226 | N/A | N/A | 126,599 |
| Other Working Capital | -385,024 | 217,219 | 914,094 | -186,000 | -420,831 |
| Other Operating Activity | 582,297 | 2,085 | -888,753 | 264,000 | 506,183 |
| Operating Cash Flow | $162,824 | $831,702 | $984,442 | $442,000 | $127,308 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -142,295 | -233,091 | -169,164 | -153,000 | -129,494 |
| Net Acquisitions | 12,682 | 123,120 | N/A | N/A | 40,579 |
| Purchase Of Investment | -11,570 | -16,912 | N/A | N/A | -188 |
| Sale Of Investment | 32,942 | 7,689 | N/A | N/A | 20,736 |
| Other Investing Activity | 0 | 0 | 769,419 | -153,000 | 0 |
| Investing Cash Flow | $-108,241 | $-119,194 | $600,255 | $-306,000 | $-68,367 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 91,508 | -100,905 | N/A | N/A | -344,854 |
| Debt Issued | 14,096 | 21,152 | N/A | N/A | 9,288 |
| Debt Repayment | -184,613 | -758,060 | N/A | N/A | -178,570 |
| Other Financing Activity | -59,779 | -127,372 | 0 | 0 | 224,479 |
| Financing Cash Flow | $-138,788 | $-965,185 | $N/A | $N/A | $-289,657 |
| Exchange Rate Effect | -22,434 | 50,793 | N/A | N/A | -4,514 |
| Beginning Cash Position | 1,185,328 | 1,387,212 | N/A | N/A | 1,427,225 |
| End Cash Position | 1,078,689 | 1,185,328 | N/A | N/A | 1,191,995 |
| Net Cash Flow | $-84,205 | $-252,677 | $N/A | $N/A | $-230,716 |
| Free Cash Flow | |||||
| Operating Cash Flow | 162,824 | 831,702 | 984,442 | 442,000 | 127,308 |
| Capital Expenditure | -145,760 | -240,690 | N/A | -312,000 | -133,900 |
| Free Cash Flow | 17,064 | 591,012 | 984,442 | 130,000 | -6,592 |